Shopping Cart
Remove All
Your shopping cart is currently empty
(R)-Atuveciclib is an isomer of Atuveciclib. Atuveciclib (BAY 1143572) is a potent and highly selective PTEFb/CDK9 inhibitor with an IC50 value of 13 nm for CDK9/CycT1 and a selectivity ratio of 100 for CDK2, with highly bioavailable and orally available advantages.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | $1,510 | 10-14 weeks | 10-14 weeks |
| Description | (R)-Atuveciclib is an isomer of Atuveciclib. Atuveciclib (BAY 1143572) is a potent and highly selective PTEFb/CDK9 inhibitor with an IC50 value of 13 nm for CDK9/CycT1 and a selectivity ratio of 100 for CDK2, with highly bioavailable and orally available advantages. |
| Targets&IC50 | CDK1-CyclinB:1100 nM, CDK3-CyclinE:890 nM, CDK9-CyclinT1:6 nM, CDK2-CyclinE:1000 nM, CDK9-CyclinT1:13 nM, CDK5-p35:1600 nM |
| Synonyms | BAY-1143572 |
| Molecular Weight | 387.43 |
| Formula | C18H18FN5O2S |
| Cas No. | 2923012-24-0 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 128.5 mg/mL (331.67 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.